Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Buttyan

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Oncogene|December 5, 2018
Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Endocrine-Related Cancer|October 6, 2023
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cellsParvin Yenki, Satyam Bhasin, Liang Liu, et al.
Oncogene|September 9, 2018
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Cell Reports|November 14, 2015
FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast CancerBingchen Han, Ying Qu, Yanli Jin, et al.
Oncotarget|February 2, 2017
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistanceMannan Nouri, Josselin Caradec, Amy Anne Lubik, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Oncogene|December 5, 2018
Correction: A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Endocrine-Related Cancer|October 6, 2023
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cellsParvin Yenki, Satyam Bhasin, Liang Liu, et al.
Oncogene|September 9, 2018
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Cell Reports|November 14, 2015
FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast CancerBingchen Han, Ying Qu, Yanli Jin, et al.
Oncotarget|February 2, 2017
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistanceMannan Nouri, Josselin Caradec, Amy Anne Lubik, et al.
Nature Communications|December 22, 2021
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancerNeha Singh, Varune R Ramnarine, Jin H Song, et al.
Pageof 7